RecruitingNot applicableNCT07283939
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Studying Cancer of unknown primary site
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Alliance for Clinical Trials in Oncology
- Principal Investigator
- Gabriel A. Brooks, MD, MPHAlliance for Clinical Trials in Oncology
- Intervention
- PAGODA algorithm(other)
- Enrollment
- 420 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2026 – 2030
Study locations (30)
- Cancer Center at Saint Joseph's, Phoenix, Arizona, United States
- Mercy Hospital Fort Smith, Fort Smith, Arkansas, United States
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro, Arkansas, United States
- CARTI Cancer Center, Little Rock, Arkansas, United States
- Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande, California, United States
- Mercy Cancer Center - Carmichael, Carmichael, California, United States
- Mercy San Juan Medical Center, Carmichael, California, United States
- Mercy Cancer Center - Elk Grove, Elk Grove, California, United States
- Mercy Cancer Center, Merced, California, United States
- Mercy Cancer Center - Rocklin, Rocklin, California, United States
- Mercy Cancer Center - Sacramento, Sacramento, California, United States
- Pacific Central Coast Health Center-San Luis Obispo, San Luis Obispo, California, United States
- Mission Hope Medical Oncology - Santa Maria, Santa Maria, California, United States
- Saint Joseph's Medical Center, Stockton, California, United States
- Woodland Memorial Hospital, Woodland, California, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07283939 on ClinicalTrials.govOther trials for Cancer of unknown primary site
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07524114Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)University Health Network, Toronto
- RECRUITINGPHASE2NCT06995508Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO TrialRoswell Park Cancer Institute
- RECRUITINGPHASE1NCT06868433TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell CancerEmory University
- RECRUITINGPHASE3NCT06589804Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous TreatmentNational Cancer Institute (NCI)
- RECRUITINGNANCT06662058Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or RadiationEmory University
- RECRUITINGPHASE2NCT06636734Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP TrialEmory University
- RECRUITINGNANCT06644716[18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary OriginErasmus Medical Center
- RECRUITINGPHASE1NCT05172245Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck CancerNational Cancer Institute (NCI)